Actively Recruiting
Led by McGill University · Updated on 2025-09-25
322
Participants Needed
4
Research Sites
21 weeks
Total Duration
M
McGill University
Lead Sponsor
I
Institut de Recherches Cliniques de Montreal
Collaborating Sponsor
Researchers are evaluating an online training and support platform called "Support" to help adults living with type 1 diabetes (T1D) manage their condition. The study aims to compare the effects of integrating this platform into regular medical care versus accessing it independently. The trial also explores factors influencing the platform's use in real-life settings and involves adults from across Canada, including those followed at four specific clinics in Quebec. Participants will be divided into two groups. One group will access the Support platform as part of their usual care, with healthcare professionals incorporating it during appointments. The other group will use the platform independently without direct integration into their medical visits. Both groups will have access to the platform for 12 months, receiving monthly newsletters and features like educational content, news blogs, and peer discussion forums, all designed to support diabetes self-management. Throughout the study, participants will complete online questionnaires at the start, 6 months, and 12 months to assess their self-efficacy and well-being. They will also share continuous glucose monitoring data and other health outcomes such as severe hypoglycemic events and diabetic ketoacidosis occurrences. A subgroup and healthcare professionals will take part in interviews to discuss experiences using the platform. The study runs from May 2024 to October 2027.
CONDITIONS
Implementation of Support in the Care of Adults Living With Type 1 Diabetes
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or remote) for eligibility assessment
Duration - 12 months
Participants receive access to the Support platform for diabetes self-management education, either integrated into their usual care or independently, along with monthly newsletters to encourage platform use.
2 to 3 visits with medical team during this period, either in-person, remote, or hybrid
Duration - 12 months
Participants complete online surveys at baseline, 6 months, and 12 months to assess self-efficacy and other health outcomes related to diabetes management.
3 online survey completions
Total: 4 locations
1
Institut de recherches cliniques de Montréal
Montreal, Quebec, Canada, H2W 1R7
Actively Recruiting
2
Centre hospitalier de l'université de Montreal
Montreal, Quebec, Canada, H2X 0C1
Actively Recruiting
3
Centre hospitalier de Quebec, Université Laval
Québec, Quebec, Canada, G1V 0E8
Actively Recruiting
4
Centre de médecine métabolique de Lanaudière
Terrebonne, Quebec, Canada, J6x 4P7
Actively Recruiting
A
Anne-Sophie Brazeau, PhD
A
amelie Roy-Fleming, MSc
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Li Feng Xie, Amélie Roy-Fleming, Sarah Haag...
https://pubmed.ncbi.nlm.nih.gov/36762025Li Feng Xie, Alexandra Itzkovitz, Amelie Roy-Fleming...
https://pubmed.ncbi.nlm.nih.gov/32788152J Kruger, A Brennan, P Thokala...
https://pubmed.ncbi.nlm.nih.gov/23815547Stephanie H Stanton-Fay, Kathryn Hamilton, Paul M Chadwick...
https://pubmed.ncbi.nlm.nih.gov/33617669Katherine Pereira, Beth Phillips, Constance Johnson...
https://pubmed.ncbi.nlm.nih.gov/25238257Geoffrey M Curran, Mark Bauer, Brian Mittman...
https://pubmed.ncbi.nlm.nih.gov/22310560Andreas Schmitt, Bernhard Kulzer, Dominic Ehrmann...
https://pubmed.ncbi.nlm.nih.gov/36994332